Preston Hollow Psychiatry Group is conveniently located along the Dallas North Tollway, serving the entire Dallas-Fort Worth Metroplex with traditional, patient-centered psychiatric medication and psychotherapy.
We are also affiliated with the Dallas Center for Advanced Depression Treatments and are able to offer patients access to the latest in interventional psychiatry techniques for treatment-resistant depression and other psychiatric disorders.Our goal is to provide a therapeutic and caring relationship with each of our patients.
We are also affiliated with the Dallas Center for Advanced Depression Treatments and are able to offer patients access to the latest in interventional psychiatry techniques for treatment-resistant depression and other psychiatric disorders.Our goal is to provide a therapeutic and caring relationship with each of our patients.
Services
Preston Hollow Psychiatry Group is a leader in advanced therapy for treatment-resistant depression. Located along the Dallas North Tollway, serving the entire DFW Metroplex, the practice is led by Marty N. Bennett, MD, a board-certified psychiatrist.
In addition to providing traditional, patient-centered psychiatric care, the practice is affiliated with the Dallas Center for Advanced Depression Treatments (CADT), the first and most experienced in the Dallas area to offer FDA-approved SPRAVATO for treatment-resistant depression.Dallas CADT also is a certified provider of BrainsWay Deep TMS, an FDA-approved treatment for major depressive disorder and obsessive-compulsive disorder (OCD).
In addition to providing traditional, patient-centered psychiatric care, the practice is affiliated with the Dallas Center for Advanced Depression Treatments (CADT), the first and most experienced in the Dallas area to offer FDA-approved SPRAVATO for treatment-resistant depression.Dallas CADT also is a certified provider of BrainsWay Deep TMS, an FDA-approved treatment for major depressive disorder and obsessive-compulsive disorder (OCD).
The Dallas Center for Advanced Depression Treatments (CADT) is a safe, comfortable and certified treatment center offering innovative therapies for treatment-resistant depression.
We deliver next-level care for patients whose depression has not responded to medication or psychotherapy, offering relief through several new, non-invasive treatments that are FDA approved for treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD) and bipolar disorders.
We deliver next-level care for patients whose depression has not responded to medication or psychotherapy, offering relief through several new, non-invasive treatments that are FDA approved for treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD) and bipolar disorders.
SPRAVATO is a breakthrough treatment for major depressive disorder. It is an intranasal prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. TRD is defined as the failure of two or more oral antidepressants of adequate dose and duration to produce a response or remission.
This is a non-invasive test that looks at the genes that may affect your body's ability to benefit from psychiatric medications and other treatments. Genomind's genetic test looks at 24 key genes that are associated with mental health. This can help your clinician to understand if a drug may work for you before you even try it.
To make a patient referral for SPRAVATO, BrainsWay Deep TMS, Abilify Maintena or intranasal ketamine, please submit the information below and a member of our staff will reach out to you as well as your patient. Additional information can be found in our Frequently Asked Questions for Providers.
Major depressive disorder (MDD), recurrent or single episode, severe with failure of at least two or more adequate trials of antidepressants (treatment resistant).Aneurysmal vascular disease (including thoracic and abdominal aorta, intracranial and peripheral arterial vessels) or arteriovenous malformation.
Major depressive disorder (MDD), recurrent or single episode, severe with failure of at least two or more adequate trials of antidepressants (treatment resistant).Aneurysmal vascular disease (including thoracic and abdominal aorta, intracranial and peripheral arterial vessels) or arteriovenous malformation.
Reviews (2)
Glinda Good Witch
Jan 28, 2022
Report
I have had been diagnosed with Major Depressive Disorder (MDD) most of my adult life. Over the last 25 years, I have been on / or tried over 20 different antidepressants and have only gotten, at best, a 5 of 10 relief. It wasn’t until I started SPRAVATO medication treatments that took me to a new level of mental well-being .. 7/8 out of 10. Life is good … again.
Dr. Bennett, Ms. Glover NP, and the staff are the best. They provide a safe and relaxing environment and monitor you throughout your treatment(s). I highly recommend this office and SPRAVATO for those who suffer from hard-to-treat
Dr. Bennett, Ms. Glover NP, and the staff are the best. They provide a safe and relaxing environment and monitor you throughout your treatment(s). I highly recommend this office and SPRAVATO for those who suffer from hard-to-treat
Joseph Canida
Jan 22, 2022
Report
I’ve been going here for Spravato treatment for a couple of months and I’ve always felt comfortable and welcome. I appreciate that the doctors here have helped me find alternate treatment methods when Spravato and my antidepressant wasn’t working well for me.
Also, shout out to Emily! She’s very kind, empathetic, and goes the extra mile for her patients. I always look forward to seeing her when I go in for appointments.
Also, shout out to Emily! She’s very kind, empathetic, and goes the extra mile for her patients. I always look forward to seeing her when I go in for appointments.
